Vault-13

PURA VIDA INVESTMENTS, LLC

NEW YORK, NY · CIK 1590144 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2014 · limited liability company

As an employer

US visa salary filings

Job titleFilingsMedianRange
Capital Markets AnalystNew York, NY 1 $175,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Pura Vida Investments, LLC.

$629.1m reported value -24.0% vs Q1 2022
104positions
47.7%in top 10
28 new 26 added 24 reduced 39 sold out vs Q1 2022

Options: 44 call positions ($348.8m notional), 55 put positions ($743.9m notional) – listed below, not included above.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 988,713 $53.8m8.55% 8.55% AddedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 962.5k, Q2 2022 988.7k +26.2k +26,219 2.7%
2 CUTERA INC COM CUTR CUTR 1,118,158 $41.9m6.67% 6.67% AddedShares held: Q3 2021 805.4k, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m +44.0k +44,007 4.1%
3 INSPIRE MED SYS INC COM INSP INSP 204,465 $37.4m5.94% 5.94% AddedShares held: Q3 2021 204.5k, Q4 2021 214.4k, Q1 2022 203.4k, Q2 2022 204.5k +1.0k +1,023 0.5%
4 VIEWRAY INC COM VRAYQ VRAYQ 13,869,108 $36.8m5.84% 5.84% AddedShares held: Q3 2021 11.2m, Q4 2021 14.1m, Q1 2022 13.6m, Q2 2022 13.9m +307.3k +307,300 2.3%
5 GLAUKOS CORP COM GKOS GKOS 796,600 $36.2m5.75% 5.75% NewShares held: Q3 2021 378.6k, Q4 2021 0, Q1 2022 0, Q2 2022 796.6k
6 BIOGEN INC COM BIIB BIIB 101,711 $20.7m3.30% 3.30% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 147.1k, Q2 2022 101.7k -45.4k -45,424 -30.9%
7 PULMONX CORP COM LUNG LUNG 1,327,065 $19.5m3.10% 3.10% AddedShares held: Q3 2021 841.8k, Q4 2021 480.1k, Q1 2022 589.7k, Q2 2022 1.3m +737.3k +737,343 125.0%
8 GUARDANT HEALTH INC COM GH GH 469,492 $18.9m3.01% 3.01% AddedShares held: Q3 2021 64.0k, Q4 2021 102.3k, Q1 2022 68.4k, Q2 2022 469.5k +401.1k +401,117 586.6%
9 NANOSTRING TECHNOLOGIES INC COM NSTG NSTG 1,469,547 $18.7m2.97% 2.97% AddedShares held: Q3 2021 1.3m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.5m +249.2k +249,215 20.4%
10 ONCOCYTE CORP COM COM 18,056,274 $16.2m2.58% 2.58% AddedShares held: Q3 2021 12.2m, Q4 2021 12.2m, Q1 2022 12.2m, Q2 2022 18.1m +5.8m +5,832,321 47.7%
11 LIVANOVA PLC SHS LIVN LIVN 256,848 $16.0m2.55% 2.55% ReducedShares held: Q3 2021 747.5k, Q4 2021 504.8k, Q1 2022 347.5k, Q2 2022 256.8k -90.7k -90,650 -26.1%
12 LYRA THERAPEUTICS INC COM LYRA LYRA 2,576,196 $14.6m2.31% 2.31% AddedShares held: Q3 2021 533.4k, Q4 2021 517.2k, Q1 2022 520.5k, Q2 2022 2.6m +2.1m +2,055,652 394.9%
13 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 60,650 $14.3m2.27% 2.27% AddedShares held: Q3 2021 8.6k, Q4 2021 10.8k, Q1 2022 16.6k, Q2 2022 60.6k +44.1k +44,089 266.2%
14 LANTHEUS HLDGS INC COM LNTH LNTH 212,238 $14.0m2.23% 2.23% ReducedShares held: Q3 2021 336.9k, Q4 2021 295.7k, Q1 2022 222.2k, Q2 2022 212.2k -10.0k -10,000 -4.5%
15 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 95,240 $13.9m2.21% 2.21% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 95.2k
16 STAAR SURGICAL CO COM PAR $0.01 STAA STAA 195,810 $13.9m2.21% 2.21% ReducedShares held: Q3 2021 166.2k, Q4 2021 161.0k, Q1 2022 196.1k, Q2 2022 195.8k -264 -264 -0.1%
17 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 162,828 $10.8m1.71% 1.71% AddedShares held: Q3 2021 50.0k, Q4 2021 0, Q1 2022 30.0k, Q2 2022 162.8k +132.8k +132,828 442.8%
18 COOPER COS INC COM NEW COM NEW 32,500 $10.2m1.62% 1.62% AddedShares held: Q3 2021 40.0k, Q4 2021 0, Q1 2022 13.0k, Q2 2022 32.5k +19.5k +19,500 150.0%
19 CYTOKINETICS INC NOTE 4.000%11/1 · principal CYTK 4 11.15.26 · principal CYTK 4 11.15.26 25,000 $9.7m1.54% 1.54% UnchangedPrincipal held: Q3 2021 25.0k, Q4 2021 25.0k, Q1 2022 25.0k, Q2 2022 25.0k
20 SOMALOGIC INC CLASS A COM SLGC SLGC 2,123,120 $9.6m1.53% 1.53% ReducedShares held: Q3 2021 1.0m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.1m -352.7k -352,695 -14.2%
21 KALVISTA PHARMACEUTICALS INC COM KALV KALV 812,828 $8.0m1.27% 1.27% AddedShares held: Q3 2021 21.9k, Q4 2021 41.1k, Q1 2022 41.4k, Q2 2022 812.8k +771.4k +771,435 1863.7%
22 APYX MEDICAL CORPORATION COM APYX APYX 1,323,303 $7.8m1.23% 1.23% AddedShares held: Q3 2021 857.0k, Q4 2021 842.6k, Q1 2022 982.7k, Q2 2022 1.3m +340.6k +340,620 34.7%
23 QUANTERIX CORP COM QTRX QTRX 437,500 $7.1m1.13% 1.13% NewShares held: Q3 2021 326.7k, Q4 2021 292.9k, Q1 2022 0, Q2 2022 437.5k
24 EVOLENT HEALTH INC CL A EVH EVH 230,000 $7.1m1.12% 1.12% AddedShares held: Q3 2021 275.0k, Q4 2021 0, Q1 2022 200.0k, Q2 2022 230.0k +30.0k +30,000 15.0%
25 IVERIC BIO INC COM OPHT OPHT 715,144 $6.9m1.09% 1.09% ReducedShares held: Q3 2021 31.8k, Q4 2021 889.5k, Q1 2022 865.1k, Q2 2022 715.1k -150.0k -150,000 -17.3%
26 OUTSET MED INC COM OM OM 443,701 $6.6m1.05% 1.05% ReducedShares held: Q3 2021 541.2k, Q4 2021 453.2k, Q1 2022 474.9k, Q2 2022 443.7k -31.2k -31,200 -6.6%
27 908 DEVICES INC COM MASS MASS 296,288 $6.1m0.97% 0.97% UnchangedShares held: Q3 2021 180.9k, Q4 2021 312.9k, Q1 2022 296.3k, Q2 2022 296.3k
28 MILESTONE PHARMACEUTICALS IN COM MIST MIST 987,411 $6.1m0.97% 0.97% UnchangedShares held: Q3 2021 850.3k, Q4 2021 931.5k, Q1 2022 987.4k, Q2 2022 987.4k
29 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 50,000 $5.4m0.86% 0.86% NewShares held: Q3 2021 130.0k, Q4 2021 0, Q1 2022 0, Q2 2022 50.0k
30 R1 RCM INC COM COM 249,732 $5.2m0.83% 0.83% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 249.7k
31 PRIVIA HEALTH GROUP INC COM PRVA PRVA 178,255 $5.2m0.83% 0.83% ReducedShares held: Q3 2021 418.6k, Q4 2021 222.5k, Q1 2022 240.2k, Q2 2022 178.3k -61.9k -61,945 -25.8%
32 AGILON HEALTH INC COM COM 236,100 $5.2m0.82% 0.82% AddedShares held: Q3 2021 447.4k, Q4 2021 231.2k, Q1 2022 45.0k, Q2 2022 236.1k +191.1k +191,100 424.7%
33 CYTEK BIOSCIENCES INC COM CTKB CTKB 477,164 $5.1m0.81% 0.81% AddedShares held: Q3 2021 444.4k, Q4 2021 421.8k, Q1 2022 424.6k, Q2 2022 477.2k +52.6k +52,587 12.4%
34 AVANTOR INC COM AVTR AVTR 155,000 $4.8m0.77% 0.77% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 155.0k
35 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 16,763 $4.7m0.75% 0.75% ReducedShares held: Q3 2021 30.0k, Q4 2021 24.6k, Q1 2022 84.1k, Q2 2022 16.8k -67.3k -67,294 -80.1%
36 ATRICURE INC COM ATRC ATRC 106,615 $4.4m0.69% 0.69% ReducedShares held: Q3 2021 479.3k, Q4 2021 376.1k, Q1 2022 336.6k, Q2 2022 106.6k -230.0k -230,000 -68.3%
37 BIOVENTUS INC COM CL A BVS BVS 599,080 $4.1m0.65% 0.65% AddedShares held: Q3 2021 429.1k, Q4 2021 552.2k, Q1 2022 555.9k, Q2 2022 599.1k +43.2k +43,170 7.8%
38 TG THERAPEUTICS INC COM TGTX TGTX 950,813 $4.0m0.64% 0.64% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 328.2k, Q2 2022 950.8k +622.6k +622,626 189.7%
39 TRAVERE THERAPEUTICS INC COM TVTX TVTX 166,201 $4.0m0.64% 0.64% AddedShares held: Q3 2021 53.8k, Q4 2021 109.9k, Q1 2022 110.2k, Q2 2022 166.2k +56.0k +55,976 50.8%
40 THE BEAUTY HEALTH COMPANY COM CL A COM CL A 305,000 $3.9m0.62% 0.62% NewShares held: Q3 2021 692.4k, Q4 2021 597.0k, Q1 2022 0, Q2 2022 305.0k
41 TELA BIO INC COM TELA TELA 555,623 $3.9m0.62% 0.62% ReducedShares held: Q3 2021 580.5k, Q4 2021 564.1k, Q1 2022 567.4k, Q2 2022 555.6k -11.8k -11,797 -2.1%
42 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 364,252 $3.9m0.61% 0.61% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 364.3k
43 KARUNA THERAPEUTICS INC COM COM 29,900 $3.8m0.60% 0.60% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 29.9k
44 CODEXIS INC COM CDXS CDXS 337,154 $3.5m0.56% 0.56% ReducedShares held: Q3 2021 476.2k, Q4 2021 463.1k, Q1 2022 465.9k, Q2 2022 337.2k -128.7k -128,748 -27.6%
45 AVITA MEDICAL INC COM RCEL RCEL 741,875 $3.5m0.56% 0.56% AddedShares held: Q3 2021 252.2k, Q4 2021 0, Q1 2022 674.3k, Q2 2022 741.9k +67.6k +67,559 10.0%
46 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 21,643 $3.4m0.54% 0.54% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 21.6k
47 SOPHIA GENETICS SA ORDINARY SHARES SOPH SOPH 859,930 $3.1m0.49% 0.49% AddedShares held: Q3 2021 450.0k, Q4 2021 0, Q1 2022 829.9k, Q2 2022 859.9k +30.0k +30,000 3.6%
48 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 183,121 $3.1m0.49% 0.49% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 183.1k
49 HUMANA INC COM HUM HUM 6,400 $3.0m0.48% 0.48% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 6.4k
50 ICAD INC COM NEW ICAD ICAD 672,989 $2.7m0.43% 0.43% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 673.0k, Q2 2022 673.0k
51 ATAI LIFE SCIENCES NV SHS ATAI ATAI 721,824 $2.6m0.42% 0.42% ReducedShares held: Q3 2021 1.3m, Q4 2021 552.8k, Q1 2022 1.3m, Q2 2022 721.8k -556.3k -556,281 -43.5%
52 SCIENCE 37 HOLDINGS INC COM COM 1,106,400 $2.2m0.35% 0.35% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.0m, Q2 2022 1.1m +100.0k +100,000 9.9%
53 NYXOAH S A SHS NYXH NYXH 221,949 $2.2m0.35% 0.35% UnchangedShares held: Q3 2021 225.2k, Q4 2021 220.6k, Q1 2022 221.9k, Q2 2022 221.9k
54 INSULET CORP COM PODD PODD 10,000 $2.2m0.35% 0.35% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 10.0k
55 COGENT BIOSCIENCES INC COM COGT COGT 238,787 $2.2m0.34% 0.34% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 238.8k
56 NATERA INC COM NTRA NTRA 60,159 $2.1m0.34% 0.34% NewShares held: Q3 2021 240.7k, Q4 2021 235.2k, Q1 2022 0, Q2 2022 60.2k
57 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 100,000 $2.1m0.34% 0.34% ReducedShares held: Q3 2021 112.3k, Q4 2021 138.7k, Q1 2022 189.4k, Q2 2022 100.0k -89.4k -89,363 -47.2%
58 ALPHA TEKNOVA INC COM TKNO TKNO 251,112 $2.1m0.34% 0.34% UnchangedShares held: Q3 2021 344.0k, Q4 2021 249.5k, Q1 2022 251.1k, Q2 2022 251.1k
59 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 208,527 $2.1m0.33% 0.33% UnchangedShares held: Q3 2021 380.0k, Q4 2021 227.4k, Q1 2022 208.5k, Q2 2022 208.5k
60 PTC THERAPEUTICS INC NOTE 3.000% 8/1 · principal PTCT 3 08.15.22 · principal PTCT 3 08.15.22 20,000 $2.0m0.32% 0.32% NewPrincipal held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 20.0k
61 EDWARDS LIFESCIENCES CORP COM EW EW 20,700 $2.0m0.31% 0.31% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 20.7k
62 AMYRIS INC COM NEW AMRS AMRS 1,050,399 $1.9m0.31% 0.31% ReducedShares held: Q3 2021 1.3m, Q4 2021 0, Q1 2022 2.5m, Q2 2022 1.1m -1.4m -1,411,037 -57.3%
63 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 789,181 $1.9m0.31% 0.31% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 789.2k
64 SONENDO INC COM COM 1,023,424 $1.8m0.28% 0.28% UnchangedShares held: Q3 2021 0, Q4 2021 877.4k, Q1 2022 1.0m, Q2 2022 1.0m
65 QUOTIENT LTD SHS SHS 6,662,019 $1.6m0.25% 0.25% ReducedShares held: Q3 2021 5.9m, Q4 2021 8.7m, Q1 2022 10.2m, Q2 2022 6.7m -3.5m -3,495,389 -34.4%
66 EXELIXIS INC COM EXEL EXEL 75,000 $1.6m0.25% 0.25% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 75.0k
67 APOLLO ENDOSURGERY INC COM COM 427,057 $1.6m0.25% 0.25% UnchangedShares held: Q3 2021 0, Q4 2021 374.7k, Q1 2022 427.1k, Q2 2022 427.1k
68 STANDARD BIOTOOLS INC COM LAB LAB 850,000 $1.4m0.22% 0.22% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 850.0k, Q2 2022 850.0k
69 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 212,123 $1.3m0.21% 0.21% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 212.1k
70 SCHRODINGER INC COM SDGR SDGR 50,000 $1.3m0.21% 0.21% UnchangedShares held: Q3 2021 121.2k, Q4 2021 0, Q1 2022 50.0k, Q2 2022 50.0k
71 LUCIRA HEALTH INC COM COM 690,663 $1.3m0.20% 0.20% AddedShares held: Q3 2021 1.0m, Q4 2021 1.2m, Q1 2022 687.2k, Q2 2022 690.7k +3.5k +3,450 0.5%
72 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 105,460 $1.2m0.19% 0.19% UnchangedShares held: Q3 2021 58.1k, Q4 2021 104.9k, Q1 2022 105.5k, Q2 2022 105.5k
73 XENON PHARMACEUTICALS INC COM XENE XENE 40,002 $1.2m0.19% 0.19% AddedShares held: Q3 2021 50.0k, Q4 2021 48.5k, Q1 2022 15.0k, Q2 2022 40.0k +25.0k +25,000 166.6%
74 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 150,000 $1.2m0.19% 0.19% UnchangedShares held: Q3 2021 255.9k, Q4 2021 0, Q1 2022 150.0k, Q2 2022 150.0k
75 VERASTEM INC COM COM 1,004,272 $1.2m0.19% 0.19% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.0m
76 BELLUS HEALTH INC NEW COM NEW BLU BLU 122,000 $1.1m0.18% 0.18% ReducedShares held: Q3 2021 334.8k, Q4 2021 387.8k, Q1 2022 390.1k, Q2 2022 122.0k -268.1k -268,097 -68.7%
77 MEDAVAIL HOLDINGS INC COM MYOS MYOS 714,120 $1.1m0.17% 0.17% UnchangedShares held: Q3 2021 714.1k, Q4 2021 714.1k, Q1 2022 714.1k, Q2 2022 714.1k
78 HEALTH SCIENCES ACQ CORP 2 ORD SHS OBIO OBIO 104,026 $1.0m0.16% 0.16% UnchangedShares held: Q3 2021 106.3k, Q4 2021 103.5k, Q1 2022 104.0k, Q2 2022 104.0k
79 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 12,900 $1.0m0.16% 0.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 12.9k
80 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 102,328 $864.0k0.14% 0.14% UnchangedShares held: Q3 2021 32.6k, Q4 2021 101.7k, Q1 2022 102.3k, Q2 2022 102.3k
81 ATHIRA PHARMA INC COM COM 268,131 $818.0k0.13% 0.13% ReducedShares held: Q3 2021 0, Q4 2021 474.3k, Q1 2022 339.5k, Q2 2022 268.1k -71.3k -71,337 -21.0%
82 CHIMERIX INC COM CMRX CMRX 384,905 $801.0k0.13% 0.13% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 384.9k
83 STRYVE FOODS INC CLASS A COM CLASS A COM 800,000 $705.0k0.11% 0.11% NewShares held: Q3 2021 575.0k, Q4 2021 437.6k, Q1 2022 0, Q2 2022 800.0k
84 GOSSAMER BIO INC COM GOSS GOSS 80,878 $677.0k0.11% 0.11% ReducedShares held: Q3 2021 90.1k, Q4 2021 87.4k, Q1 2022 87.9k, Q2 2022 80.9k -7.1k -7,051 -8.0%
85 TRAVERE THERAPEUTICS INC NOTE 2.250% 3/0 · principal TVTX 2.25 03.01.29 · principal TVTX 2.25 03.01.29 5,000 $502.0k0.08% 0.08% UnchangedPrincipal held: Q3 2021 0, Q4 2021 0, Q1 2022 5.0k, Q2 2022 5.0k
86 TRICIDA INC COM TCDA TCDA 49,900 $483.0k0.08% 0.08% ReducedShares held: Q3 2021 95.0k, Q4 2021 0, Q1 2022 180.8k, Q2 2022 49.9k -130.9k -130,916 -72.4%
87 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 14,454 $462.0k0.07% 0.07% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 29.5k, Q2 2022 14.5k -15.0k -15,000 -50.9%
88 GOSSAMER BIO INC NOTE 5.000% 6/0 · principal GOSS 5 06.01.27 · principal GOSS 5 06.01.27 5,000 $374.0k0.06% 0.06% UnchangedPrincipal held: Q3 2021 5.0k, Q4 2021 5.0k, Q1 2022 5.0k, Q2 2022 5.0k
89 RENOVACOR INC COM COM 144,925 $294.0k0.05% 0.05% ReducedShares held: Q3 2021 152.1k, Q4 2021 150.5k, Q1 2022 145.4k, Q2 2022 144.9k -465 -465 -0.3%
90 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 6,419 $239.0k0.04% 0.04% NewShares held: Q3 2021 50.0k, Q4 2021 19.1k, Q1 2022 0, Q2 2022 6.4k
91 ZYMEWORKS INC COM ZYME ZYME 44,696 $237.0k0.04% 0.04% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 44.7k
92 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 10,550 $203.0k0.03% 0.03% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 10.0k, Q2 2022 10.6k +550 +550 5.5%
93 UNITY BIOTECHNOLOGY INC COM UBXGB UBXGB 359,089 $202.0k0.03% 0.03% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.6m, Q2 2022 359.1k -1.2m -1,219,051 -77.2%
94 CONCERT PHARMACEUTICALS INC COM CNCE CNCE 44,357 $187.0k0.03% 0.03% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 44.4k
95 SOMALOGIC INC *W EXP 08/31/202 *W EXP 08/31/202 204,401 $155.0k0.02% 0.02% UnchangedShares held: Q3 2021 207.5k, Q4 2021 204.4k, Q1 2022 204.4k, Q2 2022 204.4k
96 UNIVERSE PHARMACEUTICALS INC SHS SHS 239,482 $150.0k0.02% 0.02% ReducedShares held: Q3 2021 268.0k, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 239.5k -840.0k -839,955 -77.8%
97 TALKSPACE INC *W EXP 06/21/202 TALKW TALKW 427,194 $149.0k0.02% 0.02% UnchangedShares held: Q3 2021 440.5k, Q4 2021 427.2k, Q1 2022 427.2k, Q2 2022 427.2k
98 SAVARA INC COM SVRA SVRA 95,014 $144.0k0.02% 0.02% UnchangedShares held: Q3 2021 97.5k, Q4 2021 94.4k, Q1 2022 95.0k, Q2 2022 95.0k
99 VINCERX PHARMA INC COM NEW COM NEW 108,459 $143.0k0.02% 0.02% UnchangedShares held: Q3 2021 59.8k, Q4 2021 108.2k, Q1 2022 108.5k, Q2 2022 108.5k
100 ROIVANT SCIENCES LTD *W EXP 09/30/202 *W EXP 09/30/202 199,648 $120.0k0.02% 0.02% UnchangedShares held: Q3 2021 0, Q4 2021 199.6k, Q1 2022 199.6k, Q2 2022 199.6k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
C4 THERAPEUTICS INC CCCC CCCC 624,860 $15.2m624.9k shares
BIOMARIN PHARMACEUTICAL INC BMRN BMRN 175,356 $13.5m175.4k shares
ICU MED INC ICUI ICUI 57,700 $12.8m57.7k shares
CONVEY HEALTH SOLUTIONS HLDG 1,720,752 $11.3m1.7m shares
BIO-TECHNE CORP TECH TECH 25,000 $10.8m25.0k shares
IMMUNIC INC 683,287 $7.7m683.3k shares
INTELLIA THERAPEUTICS INC NTLA NTLA 104,073 $7.6m104.1k shares
STEREOTAXIS INC STXS STXS 1,479,292 $5.5m1.5m shares
R1 RCM INC RCM RCM 188,455 $5.0m188.5k shares
CELLDEX THERAPEUTICS INC NEW CLDX CLDX 132,571 $4.5m132.6k shares
GREENLIGHT BIOSCIENCS HLDS P 400,000 $3.9m400.0k shares
PELOTON INTERACTIVE INC PTON PTON 80,000 $2.1m80.0k shares
SAREPTA THERAPEUTICS INC SRPT SRPT 25,850 $2.0m25.9k shares
LIQUIDIA CORPORATION LQDA LQDA 251,604 $1.8m251.6k shares
MERUS N V MRUS MRUS 66,547 $1.8m66.5k shares
10X GENOMICS INC TXG TXG 22,257 $1.7m22.3k shares
DA32 LIFE SCNCE TEC ACQSTN C 164,834 $1.6m164.8k shares
PROTAGONIST THERAPEUTICS INC PTGX PTGX 65,371 $1.5m65.4k shares
CHINOOK THERAPEUTICS INC ADRO ADRO 85,236 $1.4m85.2k shares
WM TECHNOLOGY INC MAPS MAPS 178,000 $1.4m178.0k shares
ADICET BIO INC 66,626 $1.3m66.6k shares
BIOHAVEN PHARMACTL HLDG CO L BHVN BHVN 10,985 $1.3m11.0k shares
NAUTILUS BIOTECHNOLOGY INC NAUT NAUT 244,698 $1.1m244.7k shares
CYCLERION THERAPEUTICS INC 776,497 $862.0k776.5k shares
CORVUS PHARMACEUTICALS INC CRVS CRVS 495,484 $813.0k495.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ISHARES TR Put Put 700,000 $118.6m700.0k shares Reduced
BIOGEN INC BIIB · Call BIIBCall 348,900 $71.2m348.9k shares Unchanged
STRYKER CORPORATION SYK · Put SYKPut 295,000 $58.7m295.0k shares Added
ISHARES TR Put Put 1,150,000 $58.0m1.1m shares Reduced
LIVANOVA PLC LIVN · Call LIVNCall 869,100 $54.3m869.1k shares Added
SPDR SER TR Put Put 500,000 $37.1m500.0k shares Reduced
FIRST TR EXCHANGE TRADED FD Put Put 330,000 $34.0m330.0k shares Added
IDEXX LABS INC IDXX · Put IDXXPut 85,000 $29.8m85.0k shares New
ARK ETF TR ARKG · Put ARKGPut 850,000 $26.8m850.0k shares Reduced
MEDTRONIC PLC MDT · Put MDTPut 270,000 $24.2m270.0k shares Reduced
VANECK ETF TRUST Put Put 300,000 $23.1m300.0k shares New
ABBOTT LABS ABT · Put ABTPut 200,000 $21.7m200.0k shares Added
METTLER TOLEDO INTERNATIONAL MTD · Put MTDPut 17,500 $20.1m17.5k shares Added
GUARDANT HEALTH INC GH · Call GHCall 465,000 $18.8m465.0k shares Added
ARK ETF TR ARKK · Put ARKKPut 450,000 $17.9m450.0k shares Reduced
CELLDEX THERAPEUTICS INC NEW CLDX · Call CLDXCall 594,800 $16.0m594.8k shares Added
PERKINELMER INC RVTY · Put RVTYPut 110,000 $15.6m110.0k shares New
PENUMBRA INC PEN · Put PENPut 125,000 $15.6m125.0k shares New
BRISTOL-MYERS SQUIBB CO Put Put 200,000 $15.4m200.0k shares New
HEALTHEQUITY INC HQY · Call HQYCall 250,000 $15.3m250.0k shares Added
PRIVIA HEALTH GROUP INC PRVA · Call PRVACall 525,000 $15.3m525.0k shares Added
SAREPTA THERAPEUTICS INC SRPT · Call SRPTCall 200,000 $15.0m200.0k shares Unchanged
MOLSON COORS BEVERAGE CO TAP · Put TAPPut 258,300 $14.1m258.3k shares Added
ALIGN TECHNOLOGY INC ALGN · Put ALGNPut 55,000 $13.0m55.0k shares New
BIONTECH SE BNTX · Call BNTXCall 80,000 $11.9m80.0k shares New

Trades reported as a company insider in Q2 2022

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2022-06-24 INSIGHT MOLECULAR DIA INC 10% owner · By the Managed Accounts. IMDX Sold 52,981 $54.8k53.0k shares -1%
2022-06-24 INSIGHT MOLECULAR DIA INC 10% owner · By Pura Vida Master Fund, Ltd. IMDX Sold 46,405 $48.0k46.4k shares -1%
2022-04-14 INSIGHT MOLECULAR DIA INC 10% owner · By Pura Vida Master Fund, Ltd. IMDX Bought 123,160 $154.3k123.2k shares +2%
2022-04-14 INSIGHT MOLECULAR DIA INC 10% owner · By the Managed Accounts. IMDX Bought 76,840 $96.2k76.8k shares +1%